Aurinia Pharmaceuticals Inc (AUPH)

Cost of Revenue

$6.56M

Quarterly · Period ending: · USD

AUPH logo

AUPH Cost of Revenue

Latest reported$6.56M
AUPH Quarterly Cost of Revenue ($265.16K → $6.56M)
High-resolution chart · PNG

AUPH cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
6,555,000
6,505,000
8,472,000
8,504,000
7,115,000
8,574,000
5,552,000
6,035,000
8,909,000
7,752,000
5,395,000
6,769,000
1,563,000
421,000
1,362,000
2,447,000
1,599,000
256,000
481,000
254,000
308,000
48,000
0
0
0
0
13,292,000
17,791,000
11,152,000
10,631,000
10,839,000
11,152,000
10,504,000
8,887,000
8,691,000
10,807,000
7,107,000
1,000
1,000
1,000
1,000
1,000
2,000
1,000
4,000
5,000
8,000
11,000
10,000
8,000
939
524,000
442,000
983
6,615
9,144
10,815
19,043
13,579
11,564
15,487
155,364
9,317
8,723
4,743
27,467
38,875
44,905
236,874
0
-155,887
1,806,159
226,960
253,570
370,291
288,074
163,457
0
165,449
158,516
128,343
0
0
0
0
0
0
0
0
0
0
0
0
0
117,664
194,070
238,707
134,804
169,713
376,580
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.